Department of Health and Social Care (DHSC) has issued a medicine supply notification for NovoRapid FlexPen® (Insulin aspart) 100units/ml solution for injection 3ml pre-filled pens.
MSN/2022/093
Tier 3 – High impact
Date of issue 4th November 2022
NovoRapid FlexPen® is out of stock until week commencing 21st November 2022.
NovoRapid Penfill® (Insulin aspart) 100units/ml cartridges remain available and can support a full uplift in demand.
Trurapi Solostar® (Insulin aspart [biosimilar]) 100units/ml pens remain available and can only support a partial uplift in demand.
NovoRapid FlexTouch® (Insulin aspart) 100units/ml pens remain available but cannot support any uplift in demand.
A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: NovoRapid FlexPen® (Insulin aspart) 100units/ml solution for injection 3ml pre-filled pens appeared first on PSNC Website.